# Efficacy and Safety Study of the Effect of Dose-Titration of Prucalopride for The Treatment of Chronic Constipation

> **NCT00577018** · PHASE3 · COMPLETED · sponsor: **Movetis** · enrollment: 755 (actual)

## Conditions studied

- Constipation

## Interventions

- **DRUG:** Prucalopride
- **DRUG:** Prucalopride
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT00577018
- **Lead sponsor:** Movetis
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1998-08
- **Primary completion:** 1999-09
- **Final completion:** 1999-09
- **Target enrollment:** 755 (ACTUAL)
- **Last updated:** 2008-05-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00577018

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00577018, "Efficacy and Safety Study of the Effect of Dose-Titration of Prucalopride for The Treatment of Chronic Constipation". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00577018. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*